BIOFRONTERA INC
(NASDAQ: BFRI)

Biofrontera, Inc. is a biopharmaceutical company, which engages in the commercialization of pharmaceutical products. It specializes in the treatment of dermatological conditions, caused primarily by exposure to sunlight that results in sun damage to the skin. The company is focused on the treatment of actinic keratosis and markets a topical antibiotic for treatment of impetigo. Its products include Ameluz and Xepi, its two prescription drugs, and BF-RhodoLED, a lamp used with Ameluz, for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company was founded on March 3, 2015 and is headquartered in Woburn, MA.

1.545

+0.395 (+34.35%)
Range 1.110 - 1.580   (42.34%)
Open -
Previous Close 1.150
Bid Price 0.480
Bid Volume 40
Ask Price 0.500
Ask Volume 9
Volume 249,340
Value -
Remark
Delayed prices. Updated at 29 Mar 2024 03:59.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis